Senior insider sale
Chief Operating Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$83.4K
16.54K shares
What this filing means
SWARTZ ROBIN plans to sell 16.54K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $83.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2025ACC: 0001959173-25-000882
Officer· Chief Operating Officer
Since Feb 2022
16.54K
Shares to sell
$83.4K
Approx. market value
6.95K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/7/2025
6.95KTotal acquired6.95K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2025 | Restricted Stock Vesting Compensation | 6.95K | — |
| Total | 6.95K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.09K
Market value
$15.7K
1/14/2025
—Completed
Units to sell
6.50K
Market value
$36.7K
12/23/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.95K
Market value
$30.9K
2/11/2025
Total
Units
16.54K
Value
$83.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/14/2025 | 3.09K | $15.7K | — | Completed |
12/23/2024 | 6.50K | $36.7K | — | Completed |
| Planned — Approximate Date | ||||
2/11/2025 | 6.95K | $30.9K | NASDAQ | Planned |
| Total | 16.54K | $83.4K | ||